The Pharmaceuticals industry on FinBizNet covers 192 listed companies, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 192 |
|---|---|
| Combined market cap | ₹22,88,335 Cr |
| Median P/E (profitable companies) | 27.8 |
| Median return on equity | 10.7% |
| Companies with latest quarterly results | 124 of 192 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.7% | ₹15,300 Cr | ₹2,911 Cr | Q1 FY27 |
| Torrent Pharma Ltd. | ₹1,73,448 Cr | 71.2 | 17.0% | ₹4,979 Cr | ₹534 Cr | Q2 FY27 |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.3% | ₹8,017 Cr | ₹952 Cr | Q1 FY27 |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.7% | ₹2,026 Cr | ₹362 Cr | Q1 FY27 |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.7% | ₹7,119 Cr | ₹787 Cr | Q1 FY27 |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.5% | ₹8,698 Cr | ₹921 Cr | Q2 FY27 |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.9% | ₹9,150 Cr | ₹1,034 Cr | Q1 FY27 |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.4% | ₹4,031 Cr | ₹570 Cr | Q1 FY27 |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.9% | ₹8,277 Cr | ₹1,417 Cr | Q1 FY27 |
| Glenmark Pharmaceuticals Limited | ₹62,838 Cr | 45.7 | 14.1% | ₹4,018 Cr | ₹483 Cr | Q1 FY27 |
| Alkem Laboratories Ltd | ₹60,380 Cr | 25.9 | 17.6% | ₹3,740 Cr | ₹521 Cr | Q1 FY27 |
| Abbott India Ltd. | ₹55,577 Cr | 35.5 | 34.5% | ₹1,814 Cr | ₹429 Cr | Q1 FY27 |
| Gland Pharma Limited | ₹50,206 Cr | 48.4 | 10.5% | ₹1,800 Cr | ₹317 Cr | Q1 FY27 |
| Ipca Laboratories Ltd. | ₹46,494 Cr | 40.5 | 13.2% | ₹2,788 Cr | ₹423 Cr | Q1 FY27 |
| Glaxosmithkline Pharmaceuticals Ltd. | ₹43,456 Cr | 40.8 | 48.9% | ₹938 Cr | ₹237 Cr | Q1 FY27 |
| Ajanta Pharma Limited | ₹41,591 Cr | 39.0 | 25.4% | ₹1,626 Cr | ₹334 Cr | Q1 FY27 |
| J.B.Chemicals & Pharmaceuticals Ltd. | ₹38,731 Cr | — | 18.7% | ₹904 Cr | ₹101 Cr | Q4 FY26 |
| Emcure Pharmaceuticals Ltd | ₹34,533 Cr | 36.3 | 19.6% | ₹2,580 Cr | ₹292 Cr | Q1 FY27 |
| Wockhardt Ltd | ₹31,766 Cr | 145.4 | 4.0% | ₹929 Cr | ₹107 Cr | Q1 FY27 |
| Piramal Pharma Ltd | ₹26,284 Cr | — | -4.0% | ₹2,270 Cr | ₹-89 Cr | Q1 FY27 |
| Acutaas Chemicals Ltd | ₹26,248 Cr | 75.2 | 23.5% | ₹330 Cr | ₹75 Cr | Q1 FY27 |
| Neuland Laboratories Ltd. | ₹25,274 Cr | 67.7 | 21.4% | ₹642 Cr | ₹148 Cr | Q1 FY27 |
| RUBICON RESEARCH LIMITED | ₹24,972 Cr | 97.6 | 19.1% | ₹534 Cr | ₹85 Cr | Q1 FY27 |
| Granules India Ltd | ₹20,461 Cr | 32.9 | 13.5% | ₹1,477 Cr | ₹180 Cr | Q1 FY27 |
| Aether Industries Limited | ₹20,419 Cr | 92.1 | 9.8% | ₹327 Cr | ₹63 Cr | Q1 FY27 |
| Shilpa Medicare Ltd. | ₹18,336 Cr | 70.7 | 9.8% | ₹466 Cr | ₹95 Cr | Q1 FY27 |
| Caplin Point Laboratories Ltdte | ₹17,484 Cr | 26.9 | 19.9% | ₹610 Cr | ₹179 Cr | Q1 FY27 |
| Pfizer Ltd. | ₹17,448 Cr | 24.1 | 17.2% | ₹653 Cr | ₹204 Cr | Q1 FY27 |
| Alivus Life Sciences Ltd | ₹16,073 Cr | 27.7 | 18.4% | ₹640 Cr | ₹160 Cr | Q1 FY27 |
| Eris Lifesciences Ltd | ₹15,877 Cr | 24.8 | 18.1% | ₹873 Cr | ₹144 Cr | Q1 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL). Showing the 30 largest of 192 companies.
FinBizNet tracks 192 listed companies in the Pharmaceuticals industry, including Sun Pharmaceutical Industries Limited, Torrent Pharma Ltd., Zydus Lifesciences Ltd, Laurus Labs Ltd, Cipla Limited, Dr.Reddys Lab, Aurobindo Pharma Ltd., Mankind Pharma, among others.
By market capitalisation, the largest Pharmaceuticals companies are Sun Pharmaceutical Industries Limited (₹4,21,995 Cr), Torrent Pharma Ltd. (₹1,73,448 Cr), Zydus Lifesciences Ltd (₹1,12,020 Cr), Laurus Labs Ltd (₹1,11,310 Cr), Cipla Limited (₹1,07,048 Cr).
The 192 Pharmaceuticals companies tracked on FinBizNet have a combined market capitalisation of about ₹22,88,335 Cr.
The median price-to-earnings ratio across 150 profitable Pharmaceuticals companies is 27.8, and the median return on equity across the industry is 10.7%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Pharmaceuticals industry.